Table 2.
Baseline characteristics comparison between groups CAC score = 0 and CAC score > 0
Variables | CAC score = 0 | CAC score > 0 | P-value |
---|---|---|---|
n (%) | 114 (69.9) | 49 (30.1) | |
Age, mean (SD) | 44.5 (9.1) | 56.9 (7.7) | < 0.001 |
Male sex, n (%) | 65 (57.0) | 31 (63.3) | 0.457 |
Dyslipidemia, n (%) | 70 (63.6) | 39 (79.6) | 0.045 |
Diabetes, n (%) | 20 (17.5) | 14 (28.6) | 0.112 |
Smoking, n (%) | 80 (70.2) | 44 (89.8) | 0.007 |
Hypertension, n (%) | 38 (33.3) | 24 (48.8) | 0.059 |
Obesity, n (%) | 46 (40.4) | 17 (34.7) | 0.496 |
LDL, unmeasurable, n (%) | 9 (8.4) | 3 (6.1) | |
LDL, measurable, n (%) | 98 (91.6) | 46 (93.9) | |
mean (SD) | 2.6 (0.9) | 2.5 (0.9) | |
HDL, mean (SD) | 1.3 (0.4) | 1.4 (0.5) | |
Triglyceride, mean (SD) | 2.2 (1.9) | 2.5 (3.0) | |
CAC score | |||
25th percentile | 13 | ||
50th percentile | 35 | ||
75th percentile | 221 | ||
90th percentile | 783 | ||
Severity of schizophreniaa | |||
CGI-SCH scorea, mean (SD) | 3.7 (1.1) | 3.6 (1.3) | 0.545 |
Duration of schizophrenia | |||
mean years (SD) | 17. 8 (7.6) | 24.1 (8.1) | < 0.001 |
Clozapine treatment, n (%) | 33 (28.9) | 8 (16.3) | 0.089 |
aBased on the CGI-SCH rating scale for overall severity.